当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析

亿帆医药

(002019)

  

流通市值:103.59亿  总市值:149.74亿
流通股本:8.41亿   总股本:12.16亿

亿帆医药(002019)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.60亿元,每股收益0.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益870841.44万元,未分配利润473455.69万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1310615.81万元,负债439774.37万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,922,709,366.042,635,110,083.181,326,616,043.25,159,823,227.64
营业总成本3,507,090,512.562,316,453,207.971,200,723,203.714,758,180,864.67
其他经营收益
营业利润435,706,848.84342,945,947.22157,061,740.52381,810,182.55
利润总额434,810,968.73344,324,147.92156,682,698.91388,656,952.28
净利润360,252,018.99284,158,135.82138,229,631.62323,621,712.62
每股收益
其他综合收益40,735,013.0361,055,565.2820,675,101.78-25,329,608.54
综合收益总额400,987,032.02345,213,701.1158,904,733.4298,292,104.08
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计4,313,556,790.113,967,724,843.293,901,724,271.73,778,271,166.02
非流动资产:
非流动资产合计8,792,601,286.988,706,415,052.418,609,163,489.228,507,516,922.73
资产总计13,106,158,077.0912,674,139,895.712,510,887,760.9212,285,788,088.75
流动负债:
流动负债合计3,401,229,033.153,032,692,512.762,848,616,568.822,987,056,324.9
非流动负债:
非流动负债合计996,514,670.64984,719,837.91,074,410,314.42871,936,425.87
负债合计4,397,743,703.794,017,412,350.663,923,026,883.243,858,992,750.77
所有者权益(或股东权益):
归属于母公司股东权益合计8,831,073,964.258,771,392,564.728,697,424,767.688,521,867,867.56
股东权益合计8,708,414,373.38,656,727,545.048,587,860,877.688,426,795,337.98
负债和股东权益合计13,106,158,077.0912,674,139,895.712,510,887,760.9212,285,788,088.75
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,051,201,019.432,774,636,043.071,411,616,036.125,327,126,585.64
经营活动现金流出小计3,725,050,032.142,488,538,971.841,229,280,618.834,686,396,392.99
经营活动产生的现金流量净额326,150,987.29286,097,071.23182,335,417.29640,730,192.65
投资活动产生的现金流量:
投资活动现金流入小计89,640,198.9189,287,620.183,820,416799,738,546.37
投资活动现金流出小计434,009,680.76248,329,030.27111,178,114.141,344,617,424.66
投资活动产生的现金流量净额-344,369,481.85-159,041,410.09-107,357,698.14-544,878,878.29
筹资活动产生的现金流量:
筹资活动现金流入小计1,618,903,373.48745,685,562.04517,987,185.772,036,620,186.4
筹资活动现金流出小计1,564,916,299.29893,098,804.57604,361,616.451,923,888,466.07
筹资活动产生的现金流量净额53,987,074.19-147,413,242.53-86,374,430.68112,731,720.33
汇率变动对现金及现金等价物的影响-2,301,795.4515,504,362.212,144,060.32-3,691,057.98
现金及现金等价物净增加额33,466,784.18-4,853,219.18-9,252,651.21204,891,976.71
期末现金及现金等价物余额811,104,642.08772,784,638.72768,385,206.69777,637,857.9
补充资料:
现金及现金等价物的净增加额--4,853,219.18-204,891,976.71
最新报告期:2025-11-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
天风证券杨松,曹文清0.500.670.872025-11-10
西南证券杜向阳0.490.650.772025-11-06
上海证券张林晚0.460.560.662025-11-05
华安证券谭国超0.490.580.692025-11-01
TOP↑